Shattuck Labs, Inc.

STTK Nasdaq SEC CIK 1680367
Follow Shattuck Labs Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0 −100% vs same quarter last year
Net income −$25.2M −150.6% vs same quarter last year
EPS, diluted −$0.14 +0% vs same quarter last year
Operating cash flow −$17.5M −95.7% vs same quarter last year
Revenue by quarter
$0
$0
$0
$1M
$0
$0
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1M−$48.8M
FY24$5.7M−$75.4M
FY23$1.7M−$87.3M
FY22$652K−$101.9M
FY21$30M−$45M
FY20$9.9M−$36.6M
FY19$9.9M−$24M
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−5150.8%−4880.9%
FY24−1408.3%−1318.1%
FY23−5549.6%−5268.4%
FY22−15848%−15635.7%
FY21−150.8%−149.8%
FY20−371.8%−368.5%
FY19−253.5%−242.6%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$40M
FY24−$60.6M
FY23−$81.6M
FY22−$106.1M
FY21−$65M
FY20−$34.4M
FY19−$21.4M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Shattuck Labs
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearShattuck LabsHealthcare median
FY25−4880.9%−30.6%
FY24−1318.1%−47%
FY23−5268.4%−58%
FY22−15635.7%−80.4%
FY21−149.8%−71.8%
FY20−368.5%−62.2%
FY19−242.6%−46.2%
FY18-−49.6%